Home
Categories
- Consumer Goods
- Finance
- Health
- Industrials
- Technology
- Cannabis
- Consumer Goods
- Finance
- Health
- Industrials
- Technology
- Cannabis
Sequire Spotlight
Events

Home
Categories
- Consumer Goods
- Finance
- Health
- Industrials
- Technology
- Cannabis
Sequire Spotlight
Events

Sequire Spotlight Presents: OS Therapies (OSTX) – Creating Pharma Technology for Children with Cancer

Host Chris Miglino interviews CEO Paul Romness. He talks about the company going public, finishing their clinical trial and FDA approval.

Featured
Healthcare
Top Video
November 12, 2024

Related Videos

Related Posts

Related Videos

Sequire Spotlight Presents: Freightos (CRGO) – A Digital Platform in the Freight Business November 14, 2024
Sequire Spotlight Presents: NewtekOne, Inc. (NEWT) – Providing Financial and Business Solutions November 12, 2024
Sequire Spotlight Presents: Beam Global (BEEM) – Sustainable Technology Innovation November 12, 2024
Sequire Spotlight Presents: NRX Pharmaceuticals Inc (NRXP) – Bringing Hope to Life July 01, 2024
Sequire Spotlight Presents: AnixaBiosciences – Immunotherapy to Prevent Cancer June 28, 2024
Sequire Spotlight Presents Tharimmune (THAR): Solving Problems for Patients with Liver Diseases June 20, 2024
Sequire Spotlight Presents Yoshitsu Co LTD (TKLF): Promoting the Tokyo Lifestyle June 20, 2024
Sequire Spotlight Presents Kimball Electronics (KE): Outsourced Work for Manufacturing June 20, 2024
Sequire Spotlight Presents: American Rebel Holdings, Inc. (AREB) – Providing Solutions to Safe Carry June 19, 2024
Sequire Spotlight Presents: Resurgent Realty Trust (RRT) – Your Gateway to Real Estate Success June 19, 2024

Related Post

Today’s Stock Market in 2-Minutes

November 14, 2024
Wrap Technologies, Inc. ($WRAP) Regains Nasdaq Listing Requirements Compliance

October 17, 2024
Athira Pharma: Advancing Bold Therapies for Neuronal Health

July 16, 2024
GT Biopharma Announces FDA Clearance of Investigational New Drug (IND) Application for GTB-3650, an NK Cell Engager for Treatment of CD33+ Leukemia

July 9, 2024

Microcaps.com is a trademark of SRAX, Inc.

Privacy Policy
Cookie Policy
Contact Us

About SRAX
About Sequire

We use cookies to improve your experience on our site, to show you personalized advertising, and as otherwise described in our Cookie Policy . To find out more, read our Privacy Policy and our Cookie Policy.